Bharat Biotech’s Covid-19 vaccine ‘Covaxin’ enters phase-3 trials
PTI, Nov 16, 2020, 4:10 PM IST
New Delhi: Covid-19 vaccine, Covaxin, being developed by Bharat Biotech is now undergoing phase-3 trials, Krishna Ella, Chairman and Managing Director, Bharat Biotech said on Monday.
Speaking virtually at a programme organised by the Indian School of Business, Ella said the company is also working on another vaccine for Covid-19 which would be in the form of nasal drops and can be ready by next year.
“We partnered with ICMR for Covid-19 vaccine as we speak it entered the phase 3 trials,” he said.
Bharat Biotech is the only vaccine company in the world which has BSL3 production facility (Biosafety level 3), he said.
Last month the vaccine maker said it had successfully completed interim analysis of Phase I and II trials of the vaccine and is initiating Phase-III trials in 26,000 participants.
Covaxinis being developed by Bharat Biotech, in collaboration with the Indian Council of Medical Research (ICMR) – National Institute of Virology (NIV).
The city-based vaccine maker had on October 2 sought the Drug Controller General of India’s (DCGI) permission to conduct phase 3 randomised double-blind placebo-controlled multicentre trial of its Covid-19 vaccine, sources said.
“We are working on another vaccine through nasal drops my feeling is by next year it will reach the population,” Ella said.
Bharat Biotech in September said it entered into a licensing agreement with Washington University School of Medicine in St. Louis for a novel “chimp-adenovirus” (Chimpanzee adenovirus), single-dose intranasal vaccine for Covid-19.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Speculation rife in Karnataka as CM convenes meeting of cabinet, MPs
Farmers’ protest: Vigil stepped up in Delhi’s bordering areas, vehicles being checked
Khattar hits out at Amarinder, tells him to stop ‘inciting’ innocent farmers
Related Articles More
K’taka COVID-19 update: 1630 new cases, 1333 discharges, 19 deaths on Nov 24
PM has indicated COVID vaccine likely to be ready soon: Yediyurappa
K’taka COVID-19 update: 1870 new cases, 1949 discharges, 17 deaths on Nov 23
Thanksgiving could be make-or-break in US virus response
COVID-19 vaccine: India Aatmanirbhar for syringes, says industry
Madhavashankara name for Mangalore airport: Shri Sugunendra Tirtha Swamiji
Centuries-old Tuluva ritual of ‘Bhoomipuje Gaddekori’ still performed at Palthadi Village in Puttur
A bike rider dies in a lorry crash : The scene of the accident was captured on CCTV
Moodbidri: Four people drowned in Shambhavi river
1348 new vented dams in K’taka’s coastal districts: J.C. Madhu Swamy
Chinese Premier Li to Attend SCO Heads of Govt Meeting Hosted by India on November 30
Phone Call Row: RJD Chief Lalu Prasad Shifted from Hospital Director’s Bungalow to Paying Ward
India, Nepal Agree to Advance Ties as Foreign Secretary Meets Nepalese Top Leadership
Former Assam CM Tarun Gogoi Cremated With Full State Honours in Guwahati
UP govt extends ban on strikes in state departments for 6 months